Short Interest in Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Increases By 400.0%

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) was the target of a significant increase in short interest in March. As of March 31st, there was short interest totalling 500 shares, an increase of 400.0% from the March 15th total of 100 shares. Based on an average trading volume of 2,700 shares, the short-interest ratio is presently 0.2 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Price Performance

NASDAQ HROWM traded down $0.45 during trading hours on Tuesday, hitting $25.90. 1,838 shares of the company were exchanged, compared to its average volume of 3,662. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 52-week low of $24.90 and a 52-week high of $27.70. The company has a 50 day moving average of $26.57 and a two-hundred day moving average of $26.46.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Tuesday, April 15th will be issued a dividend of $0.7422 per share. This represents a $2.97 annualized dividend and a yield of 11.46%. The ex-dividend date of this dividend is Tuesday, April 15th.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Company Profile

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.